Profil bibliographique

Preeti K. Parhar

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

40Publications signalées

823Citations signalées

0Affiliations récentes

Domaines associés

Advanced Radiotherapy TechniquesBreast Cancer Treatment StudiesCancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesCAR-T cell therapy research

Publications récentes

2024 conference-abstractOpenAlex

P-683 Progestins vs flexible GnRH antagonist for LH suppression during controlled ovarian stimulation in POSEIDON groups 3 and 4 patients: Analysis of effectiveness and cycle outcomes

Preeti K. Parhar, P Addagatla, Durga Gedela Rao, K Chaitanya

1 citationHuman Reproduction

Accès ouvert 2024 articleOpenAlex

Validation of Patient-Reported Outcomes in Patients With Nonmetastatic Breast Cancer Receiving Comprehensive Nodal Irradiation in the RadComp Trial

Elizabeth A. Hahn, Stephanie L. Pugh, Hien L. Lu, Alyssa Vela et autres

3 citationsInternational Journal of Radiation Oncology*Biology*Physics

Accès ouvert 2023 conference-abstractOpenAlex

P-671 Comparing clomiphene citrate/ flexible GnRH antagonist vs ultrashort flare GnRH agonist protocols for controlled ovarian stimulation in poor ovarian reserve patients

Preeti K. Parhar, Nehal N. Mehta, Durga Gedela Rao, K Chaitanya

1 citationHuman Reproduction

Accès ouvert 2023 otherOpenAlex

Data from Concurrent Radiotherapy and Ipilimumab Immunotherapy for Patients with Melanoma

Christopher A. Barker, Michael A. Postow, Shaheer Khan, Kathryn Beal et autres

0 citations

Accès ouvert 2023 supplementary-materialsOpenAlex

Supplementary Table 2 from Concurrent Radiotherapy and Ipilimumab Immunotherapy for Patients with Melanoma

Christopher A. Barker, Michael A. Postow, Shaheer Khan, Kathryn Beal et autres

0 citations

Accès ouvert 2023 supplementary-materialsOpenAlex

Supplementary Table 1 from Concurrent Radiotherapy and Ipilimumab Immunotherapy for Patients with Melanoma

Christopher A. Barker, Michael A. Postow, Shaheer Khan, Kathryn Beal et autres

0 citations

Accès ouvert 2023 supplementary-materialsOpenAlex

Supplementary Table 1 from Concurrent Radiotherapy and Ipilimumab Immunotherapy for Patients with Melanoma

Christopher A. Barker, Michael A. Postow, Shaheer Khan, Kathryn Beal et autres

0 citations

Accès ouvert 2023 supplementary-materialsOpenAlex

Supplementary Table 2 from Concurrent Radiotherapy and Ipilimumab Immunotherapy for Patients with Melanoma

Christopher A. Barker, Michael A. Postow, Shaheer Khan, Kathryn Beal et autres

0 citations

Accès ouvert 2023 otherOpenAlex

Data from Concurrent Radiotherapy and Ipilimumab Immunotherapy for Patients with Melanoma

Christopher A. Barker, Michael A. Postow, Shaheer Khan, Kathryn Beal et autres

0 citations

2020 articleOpenAlex

Outcomes and Toxicities Associated with Proton Beam Reirradiation for Breast Cancer: Prospective Results from the Proton Collaborative Group Registry

X. Li, Shaakir Hasan, Robert H. Press, Preeti K. Parhar et autres

1 citationInternational Journal of Radiation Oncology*Biology*Physics

Accès ouvert 2018 articleOpenAlex

Long-Term Pulmonary Outcomes of a Feasibility Study of Inverse-Planned, Multibeam Intensity Modulated Radiation Therapy in Node-Positive Breast Cancer Patients Receiving Regional Nodal Irradiation

Alice Y. Ho, Åse Ballangrud, Guang Li, Gaorav P. Gupta et autres

54 citationsInternational Journal of Radiation Oncology*Biology*Physics

2018 articleOpenAlex

Prospective Personalized Elective Nodal Dose De-Escalation in Patients with Human Papillomavirus (HPV)-Positive Oropharyngeal Cancer (OPC) Undergoing Definitive Concurrent Chemoradiation (CCRT): Acute Toxicities and Tolerance

C.J. Tsai, J.K. Kim, Sean M. McBride, Daphna Y. Gelblum et autres

4 citationsInternational Journal of Radiation Oncology*Biology*Physics

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.